Context Therapeutics, Inc. (CNTX)
0.1645
-0.01
(-3.80%)
USD |
NASDAQ |
Nov 18, 16:00
0.1645
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Enterprise Value : -18.49M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | -18.49M |
| November 16, 2026 | -18.96M |
| November 13, 2026 | -17.59M |
| November 12, 2026 | -16.01M |
| November 11, 2026 | -14.35M |
| November 10, 2026 | -17.02M |
| November 09, 2026 | -15.80M |
| November 06, 2026 | -16.43M |
| November 05, 2026 | -16.94M |
| November 04, 2026 | -15.51M |
| November 03, 2026 | -16.38M |
| November 02, 2026 | -15.64M |
| October 30, 2026 | -16.83M |
| October 29, 2026 | -15.67M |
| October 28, 2026 | -14.79M |
| October 27, 2026 | -12.64M |
| October 26, 2026 | -12.16M |
| October 23, 2026 | -12.22M |
| October 22, 2026 | -12.56M |
| October 21, 2026 | -12.94M |
| October 20, 2026 | -11.80M |
| October 19, 2026 | -12.30M |
| October 16, 2026 | -11.79M |
| October 15, 2026 | -12.11M |
| October 14, 2026 | -10.72M |
| Date | Value |
|---|---|
| October 13, 2026 | -8.938M |
| October 12, 2026 | -6.181M |
| October 09, 2026 | -6.255M |
| October 08, 2026 | -6.732M |
| October 07, 2026 | -5.483M |
| October 06, 2026 | -4.638M |
| October 05, 2026 | -3.287M |
| October 02, 2026 | -5.749M |
| October 01, 2026 | -5.318M |
| September 30, 2026 | -6.604M |
| September 29, 2026 | -13.44M |
| September 28, 2026 | -12.77M |
| September 25, 2026 | -10.98M |
| September 24, 2026 | -8.649M |
| September 23, 2026 | -7.592M |
| September 22, 2026 | -6.995M |
| September 21, 2026 | -8.328M |
| September 18, 2026 | -8.925M |
| September 17, 2026 | -7.519M |
| September 16, 2026 | -7.923M |
| September 15, 2026 | -9.265M |
| September 14, 2026 | -10.50M |
| September 11, 2026 | -10.55M |
| September 10, 2026 | -9.081M |
| September 09, 2026 | -8.750M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| EyePoint, Inc. | -69.60M |
| Neumora Therapeutics, Inc. | 31.03M |
| LENZ Therapeutics, Inc. | -86.87M |
| ANI Pharmaceuticals, Inc. | 1.774B |
| Corcept Therapeutics, Inc. | 7.301B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.624M |
| Total Expenses (Quarterly) | 7.624M |
| EPS Diluted (Quarterly) | -0.0801 |
| Earnings Yield | -283.3% |
| Normalized Earnings Yield | -283.28 |